Our result confirmed that LC3II/I ratio is unchanged in MM-treated Ctrl cells, yet due to the absence of LAMP2, KO cells already showed an increased LC3II/I ratio at baseline, which was further increased by MM treatment. This evidence concerns the gene LAMP2 and Miyoshi myopathy.